CoreAge Rx vs AbundRX
Two GLP-1 providers, one scoreboard. We put CoreAge Rx and AbundRX head-to-head on the published Brief Score — the same six factors, scored the same way.
CoreAge Rx
The verdict
CoreAge Rx takes this head-to-head.
CoreAge Rx scores 94 to 66 on our six-factor Brief Score — CoreAge publishes different starting offers across its pages; the advertised annual rates require a full year paid upfront.
That doesn't make AbundRX a bad call — it's best for people comparing an itemized self-pay quote after provider review. Weigh the six factors below against your own priorities before you decide.
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Brief Score.
Factor by factor
Both providers scored on the six published Brief Score factors. The higher score in each row is marked. See the methodology.
Price, coverage & the tracker
| Compare | CoreAge Rx | AbundRX |
|---|---|---|
| Brief Score | 94/100 (A) | 66/100 (C) |
| Semaglutide | From $79/mo Annual offer: 12 months paid upfront, from $948. Main site: from $99/mo; confirm the selected offer. Full price detailsFrom $79/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($948 at that starting rate); main product page separately advertises from $99/mo | From $99 Supply period and renewal amount not published for this starting figure. Full price detailsCompounded semaglutide offered; complete selected-plan quote unknown; From $99. Supply period and renewal amount not published for this starting figure. |
| Tirzepatide | From $129/mo Annual offer: 12 months paid upfront, from $1,548. Main site: from $149/mo; confirm the selected offer. Full price detailsFrom $129/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($1,548 at that starting rate); main product page separately advertises from $149/mo | From $149 Supply period and renewal amount not published for this starting figure. Full price detailsCompounded tirzepatide offered; complete selected-plan quote unknown; From $149. Supply period and renewal amount not published for this starting figure. |
| Coverage | US only; restrictions by state, confirmed at intake | Complete service-state list is not published on the program page. |
| Brand-name access | Not confirmed | Not confirmed |
| Oral / sublingual | Injection only | Injection only |
| On the tracker | Stableprice stable | Newnew to the tracker, no prior reading |
CoreAge Rx: The checked annual-plan offer starts at $79/$129 per month on annual prepay; the main product pages still show $99/$149. Confirm the selected offer.
AbundRX: AbundRX lists $99 and $149 starting prices. Its public pages leave the supply period and renewal charge open until the care plan is known.
Pricing, states and access reflect each provider's public disclosures at last review; the Brief Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.